Finanzen von Sensus Healthcare Inc (SRTS)SRTSSensus Healthcare Inc

Sensus Healthcare Inc (SRTS) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Product Revenue, accounting for 58.8% of total sales, equivalent to $2.00M. Another important revenue stream is Service Revenue. Understanding this composition is critical for investors evaluating how SRTS navigates market cycles within the Advanced Medical Equipment & Technology industry.

Evaluating the bottom line, Sensus Healthcare Inc maintains a gross margin of 33.58%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -138.86%, while the net margin is -382.05%. These profitability ratios, combined with a Return on Equity (ROE) of -34.83%, provide a clear picture of how effectively SRTS converts its operational activities into shareholder value.

In the context of the broader market, SRTS competes directly with industry leaders such as SNWV and DAVI. With a market capitalization of $48.06M, it holds a leading position in the sector. When comparing efficiency, SRTS's gross margin of 33.58% stands against SNWV's 73.65% and DAVI's N/A. Such benchmarking helps identify whether Sensus Healthcare Inc is trading at a premium or discount relative to its financial performance.

Sensus Healthcare has experienced a significant decline in revenue, reporting $2.3 million in Q2 2026, down 68.5% year-over-year. The gross margin has also decreased to 33.58%, reflecting challenges in profitability. The company has reported consistent net losses, with a net loss of $8.7 million in Q2 2026, indicating ongoing financial difficulties.